Holocene Advisors
CMD

Holocene Advisors’s Cantel Medical Corporation CMD Stock Holding History

Holocene Advisors’s Portfolio CMD Stock Details CMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-16,823
Closed -$1.36M – 898
2019
Q2 		$1.36M Buy
16,823
+9,994
+146% +$703K 0.02% 237
2019
Q1 		$457K Buy
+6,829
New +$517K 0.01% 429
2018
Q4 		– Sell
-9,168
Closed -$844K – 903
2018
Q3 		$844K Buy
+9,168
New +$873K 0.01% 374

Other funds holding CMD

BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

Holocene Advisors's CMD Position: Q3 2019 in Review

Holocene Advisors sold out of Cantel Medical Corporation (CMD) in Q3 2019, closing a stake of 16,823 shares — an estimated $1.36M sold.

Holocene Advisors first reported a position in CMD in Q3 2018 and held it in 3 quarters. The position peaked at $1.36M in Q2 2019. 244 funds tracked by Wall St. Rank hold CMD as of Q3 2019.

  • Holocene Advisors reported no remaining Cantel Medical Corporation position as of Q3 2019 after selling out during the quarter.
  • Holocene Advisors sold 16,823 Cantel Medical Corporation shares in Q3 2019, an estimated $1.36M.
  • Holocene Advisors first reported a position in Cantel Medical Corporation in Q3 2018 and held it in 3 quarters.
  • Holocene Advisors's Cantel Medical Corporation position peaked at $1.36M in Q2 2019.
  • 244 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q3 2019.

Based on Holocene Advisors's 13F filing for Q3 2019, filed 14 Nov 2019.